Armitage, J. (2008). Commentary on NICE technology appraisal guidance on ezetimibe for the treatment of primary (heterozygous-familial and non-familial) hypercholesterolaemia.
Chicago Style (17th ed.) CitationArmitage, J. Commentary on NICE Technology Appraisal Guidance on Ezetimibe for the Treatment of Primary (heterozygous-familial and Non-familial) Hypercholesterolaemia. 2008.
MLA引文Armitage, J. Commentary on NICE Technology Appraisal Guidance on Ezetimibe for the Treatment of Primary (heterozygous-familial and Non-familial) Hypercholesterolaemia. 2008.
警告：這些引文格式不一定是100％准確.